Milchael Wilken

Title: Milchael Wilken: Innovator in Immunology

Introduction

Milchael Wilken is a notable inventor based in Hundested, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative research and patenting of human antibodies.

Latest Patents

Milchael Wilken holds a patent titled "Nucleic acids encoding human anti-kir antibodies." This patent describes compositions and methods for regulating an immune response in a subject. More specifically, it details human antibodies that regulate the activity of natural killer (NK) cells, enhancing NK cell cytotoxicity in mammalian subjects. The patent also covers antibodies with antigen-binding properties similar to those of human monoclonal antibodies 1-7F9 or 1-4F1. Additionally, it describes fragments and derivatives of these antibodies, as well as pharmaceutical compositions that utilize them, particularly for therapeutic applications aimed at increasing NK cell activity or cytotoxicity.

Career Highlights

Throughout his career, Milchael Wilken has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Novo Nordisk A/S and Innate Pharma S.A.S. His work in these organizations has contributed to advancements in therapeutic strategies targeting immune responses.

Collaborations

Milchael has collaborated with esteemed colleagues in the field, including Alessandro Moretta and Mariella Della Chiesa. These partnerships have further enriched his research and development efforts.

Conclusion

Milchael Wilken's innovative work in the field of immunology, particularly through his patent on human antibodies, showcases his commitment to advancing therapeutic solutions. His collaborations and career experiences reflect his significant impact on the scientific community.